Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...

Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...

The US Food and Drug Administration intends to put a ‘black box’ warning on COVID-19 vaccines, CNN reported on Friday, citing ...

Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a ...

The plan has not been finalized and may still change, CNN reported. It was not immediately clear whether the plans for the ...

Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

Novavax, Inc. reported a 3Q25 EPS loss and declining revenue, but beat revenue expectations and reaffirmed its FY25 guidance, driven by Sanofi partnership milestones. Novavax's heavy reliance on ...

The FDA will reportedly add a “black box” warning to Covid-19 vaccines as the Trump administration steps up its attack on ...

We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

In July, the FDA updated the warning label for the Pfizer and Moderna Covid vaccines to warn that the risk of myocarditis and pericarditis, inflammation of the membranes surrounding the heart, was ...